Genotypic Distribution of the Human Papillomavirus among Women with Cervical Cytological Abnormalities at the Sour？ SANOU University Hospital in Bobo-Dioulasso, Burkina Faso
Cervical cancer is the fourth most common cancer worldwide, accounting for 6.8% of new cancer cases and 8.1% of cancer-related deaths. About 85% of these deaths occurred in low- and middle-income countries. The aim of this study was to assess the frequency and distribution of the human papillomavirus (HPV) genotypes in women showing cytological abnormalities of the cervix at the Sour？ SANOU University Hospital (CHUSS) in Bobo-Dioulasso, Burkina Faso. This is a descriptive study of women recruited at the CHUSS. The cervico-uterine smear examination was carried out at the CHUSS Anatomy and Pathology Department for cervical cancer screening. The data were collected from women with atypical cells on their cervico-uterine smear. Cervicovaginal samples were taken from consenting women and HPV genotyping was performed using the HPV Direct FLOW CHIP kit at CERBA. We obtained approval from the ethics committee. The data were analyzed using the SPSS 26 software. The results of the study showed that 67.79% of the participants were aged between 50 and 65, a group that is particularly vulnerable to persistent infection with high-risk oncogenic HPV genotypes. Of the women screened, 40.7% were HPV positive and 29.2% had multiple infections. The most common genotypes were HPV 35, followed by HPV 18, 52, 58 and 66. These data highlight the need for increased surveillance and targeted prevention strategies among this female population.
References
[1]
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. https://doi.org/10.3322/caac.21834
[2]
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., et al. (2018) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. https://doi.org/10.1002/ijc.31937
[3]
Marie Tebeu, P., Saint Saba Antaon, J., Adjeba, M., Pikop, F., Tsuala Fouogue, J. and Ndom, P. (2021) Connaissances, attitudes et pratiques des professionnels de santé sur le cancer du col de l’utérus au Cameroun. Santé Publique, 32, 489-496. https://doi.org/10.3917/spub.205.0489
[4]
Mboumba Bouassa, R.S., Prazuck, T., Lethu, T., Meye, J.F. and Bélec, L. (2017) Cervical Cancer in Sub-Saharan Africa: An Emerging and Preventable Disease Associated with Oncogenic Human Papillomavirus. Médecine et Santé Tropicales, 27, 16-22. https://doi.org/10.1684/mst.2017.0648
[5]
Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17. https://doi.org/10.1128/cmr.16.1.1-17.2003
[6]
Clavel, C., Dalstein, V. and Birembaut, P. (2008) Stratégies de dépistage des lésions précancéreuses du col de l’utérus: Cytologie ou test HPV? Revue Francophone des Laboratoires, 2008, 57-65. https://doi.org/10.1016/s1773-035x(08)74279-5
[7]
OMS (2007) La lutte contre le cancer du col de l’utérus: Guide des pratiques essentielles. Organisation mondiale de la santé.
[8]
Bergeron, C. (2008) HVP et cancer: Classification des lésions. Revue Francophone des Laboratoires, 2008, 43-50. https://doi.org/10.1016/s1773-035x(08)74277-1
[9]
Bayo, S., Bosch, F.X., de Sanjosé, S., Muñoz, N., Combita, A.L., Coursaget, P., et al. (2002) Risk Factors of Invasive Cervical Cancer in Mali. International Journal of Epidemiology, 31, 202-209. https://doi.org/10.1093/ije/31.1.202
[10]
Ouédraogo, C., Zohoncon, T.M., Traoré, E.M.A., Ouattara, S., Bado, P., Ouedraogo, C.T., et al. (2016) Distribution of High-Risk Human Papillomavirus Genotypes in Precancerous Cervical Lesions in Ouagadougou, Burkina Faso. Open Journal of Obstetrics and Gynecology, 6, 196-204. https://doi.org/10.4236/ojog.2016.64025
[11]
Monsonego, J. (2007) Prévention du cancer du col utérin (I): Apport du dépistage, récents progrès et perspectives. La Presse Médicale, 36, 92-111. https://doi.org/10.1016/j.lpm.2006.10.023
[12]
Mpiga, E., Ivanga, M., Koumakpayi, H., Engohan-Aloghe, C., Ankély, J.C., Belembaogo, E., et al. (2015) Intérêt de l’inspection visuelle à l’acide acétique et au soluté de Lugol avec colposcope dans le dépistage des lésions du col utérin au Gabon. Pan African Medical Journal, 22, Article 165. https://doi.org/10.11604/pamj.2015.22.165.7038
[13]
Dumont, A., Bessières, N., Razafindrafara, G., Ravit, M. and Benbassa, A. (2019) Intérêt du test HPV dans le dépistage primaire du cancer du col en milieu rural à Madagascar. Revue d’Épidémiologie et de Santé Publique, 67, 120-125. https://doi.org/10.1016/j.respe.2018.10.003
[14]
Kabre, K.M., Ouermi, D., Zohoncon, T.M., Traore, F.P.W., Gnoumou, O.P.D.P., Ouedraogo, R.A., et al. (2022) Molecular Epidemiology of Human Papillomavirus in Pregnant Women in Burkina Faso. Biomolecular Concepts, 13, 334-340. https://doi.org/10.1515/bmc-2022-0026
[15]
Zhao, S., Zhao, X., Hu, S., Lu, J., Duan, X., Zhang, X., et al. (2019) Distribution of High-Risk Human Papillomavirus Genotype Prevalence and Attribution to Cervical Precancerous Lesions in Rural North China. Chinese Journal of Cancer Research, 31, 663-672. https://doi.org/10.21147/j.issn.1000-9604.2019.04.10
[16]
Ma, L., Cong, X., Shi, M., Wang, X., Liu, H. and Bian, M. (2016) Distribution of Human Papillomavirus Genotypes in Cervical Lesions. Experimental and Therapeutic Medicine, 13, 535-541. https://doi.org/10.3892/etm.2016.4000
[17]
Wang, J., Tang, D., Wang, J., Zhang, Z., Chen, Y., Wang, K., et al. (2019) Genotype Distribution and Prevalence of Human Papillomavirus among Women with Cervical Cytological Abnormalities in Xinjiang, China. Human Vaccines & Immunotherapeutics, 15, 1889-1896. https://doi.org/10.1080/21645515.2019.1578598
[18]
Salifou, K., Brun, L., Akpona, L.F.J., Obossou, A.A.A. and René-Xavier, P. (2015) Facteurs associés aux lésions précancéreuses et cancéreuses du col de l’utérus dans la ville de Parakou au Bénin. European Scientific Journal, 11, 275-283.
[19]
Bel Haj Rhouma, R., Ardhaoui, M., El Fehri, E., Marzougui, A., Laassili, T., Guizani, I., et al. (2021) Distribution of Human Papillomavirus in Precancerous and Cancerous Cervical Neoplasia in Tunisian Women. Infectious Agents and Cancer, 16, Article No. 52. https://doi.org/10.1186/s13027-021-00392-1
[20]
Zohoncon, T.M., Saoura, E.F.T., Konsegre, V., Ouedraogo, E., Ouedraogo, R.A., Ouedraogo, S., Ouattara, A.K., Simpore, J. and Lompo, O.M. (2023) Génotypes HPV à Haut Risque Impliqués Dans Les Lésions Précancéreuses et Cancéreuses Du Col de l’utérus Au Burkina Faso: Revue Systématique de Littérature. Science et Technique, Sciences de la Santé, 46, 125-141.
[21]
Alarcón-Romero, L.D.C., Organista-Nava, J., Gómez-Gómez, Y., Ortiz-Ortiz, J., Hernández-Sotelo, D., del Moral-Hernández, O., et al. (2022) Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association with Cervical Cancer and Precursor Lesions in Women from Southern Mexico. Cancer Control, 29. https://doi.org/10.1177/10732748221103331
[22]
Tagne Simo, R., Djoko Nono, A.G., Fogang Dongmo, H.P., Seke Etet, P.F., Fonyuy, B.K., Kamdje, A.H.N., et al. (2021) Prevalence of Precancerous Cervical Lesions and High-Risk Human Papillomavirus Types in Yaounde, Cameroon. The Journal of Infection in Developing Countries, 15, 1339-1345. https://doi.org/10.3855/jidc.15218
[23]
Maria, H., Dana, H., Françoise, M., Michael, P. and Jürgen, W. (2018) Human Papillomaviruses in Western Africa: Prevalences and Risk Factors in Burkina Faso. Archives of Gynecology and Obstetrics, 298, 789-796. https://doi.org/10.1007/s00404-018-4860-z
[24]
Didelot-Rousseau, M., Nagot, N., Costes-Martineau, V., Vallès, X., Ouedraogo, A., Konate, I., et al. (2006) Human Papillomavirus Genotype Distribution and Cervical Squamous Intraepithelial Lesions among High-Risk Women with and without HIV-1 Infection in Burkina Faso. British Journal of Cancer, 95, 355-362. https://doi.org/10.1038/sj.bjc.6603252
[25]
Zohoncon, T.M., Bado, P., Ouermi, D., Traoré, E.M.A., Ouattara, S., Djigma, F.W., Traore, I.M.A., Yonli, A.T., Obiri-Yeboah, D., Ouédraogo, C., Akpona, S.A., Lompo, O. and Simpore, J. (2016) Molecular Characterization of High-Risk Human Papillomavirus Genotypes Involved in Invasive Cervical Cancer from Formalin-Fixed, Paraffin-Embedded Tissues in Ouagadougou, Burkina Faso. International Journal of Current Research, 8, 39314-39318.
[26]
Guan, P., Howell-Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., et al. (2012) Human Papillomavirus Types in 115,789 HPV-Positive Women: A Meta-Analysis from Cervical Infection to Cancer. International Journal of Cancer, 131, 2349-2359. https://doi.org/10.1002/ijc.27485
[27]
Ouedraogo, C.M.R., Djigma, F.W., Bisseye, C., Sagna, T., Zeba, M., Ouermi, D., et al. (2011) Épidémiologie et caractérisation des génotypes de papillomavirus humain dans une population de femmes à Ouagadougou. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 40, 633-638. https://doi.org/10.1016/j.jgyn.2011.05.012
[28]
Ouedraogo, R.A., Zohoncon, T.M., Ouattara, A.K. and Simpore, J. (2020) Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso: Predominance of Human Papillomavirus 56 in a Subpopulation of Sexually Active Women in Garango, Central-East, Burkina Faso. Journal of Applied Biosciences, 150, 15499-15509. https://doi.org/10.35759/jabs.150.10
[29]
Ouedraogo, R.A., Zohoncon, T.M., Guigma, S.P., Angèle Traore, I.M., Ouattara, A.K., Ouedraogo, M., et al. (2018) Oncogenic Human Papillomavirus Infection and Genotypes Characterization among Sexually Active Women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Research, 6, 22-26. https://doi.org/10.1016/j.pvr.2018.09.001
[30]
Ouedraogo, R.A., Kande, A., Nadembega, W.M.C., Ouermi, D., Zohoncon, T.M., Djigma, F.W., et al. (2023) Distribution of High-And Low-Risk Human Papillomavirus Genotypes and Their Prophylactic Vaccination Coverage among West African Women: Systematic Review. Journal of the Egyptian National Cancer Institute, 35, Article No. 39. https://doi.org/10.1186/s43046-023-00196-x
